Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-26-036286
Filing Date
2026-03-30
Accepted
2026-03-27 17:54:32
Documents
114
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K hypd-20251231x10k.htm   iXBRL 10-K 3754539
2 EX-3.1.6 hypd-20251231xex3d16.htm EX-3.1-6 99469
3 EX-4.13 hypd-20251231xex4d13.htm EX-4.13 113067
4 EX-10.25 hypd-20251231xex10d25.htm EX-10.25 482448
5 EX-23.1 hypd-20251231xex23d1.htm EX-23.1 2131
6 EX-23.2 hypd-20251231xex23d2.htm EX-23.2 2119
7 EX-31.1 hypd-20251231xex31d1.htm EX-31.1 12997
8 EX-31.2 hypd-20251231xex31d2.htm EX-31.2 13030
9 EX-32.1 hypd-20251231xex32d1.htm EX-32.1 6187
10 EX-32.2 hypd-20251231xex32d2.htm EX-32.2 6424
  Complete submission text file 0001104659-26-036286.txt   16781312

Data Files

Seq Description Document Type Size
11 EX-101.SCH hypd-20251231.xsd EX-101.SCH 125717
12 EX-101.CAL hypd-20251231_cal.xml EX-101.CAL 87357
13 EX-101.DEF hypd-20251231_def.xml EX-101.DEF 412769
14 EX-101.LAB hypd-20251231_lab.xml EX-101.LAB 798329
15 EX-101.PRE hypd-20251231_pre.xml EX-101.PRE 721756
118 EXTRACTED XBRL INSTANCE DOCUMENT hypd-20251231x10k_htm.xml XML 3032327
Mailing Address 295 MADISON AVENUE SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE SUITE 2400 NEW YORK NY 10017 833-393-6684
HYPERION DEFI, INC. (Filer) CIK: 0001682639 (see all company filings)

EIN.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38365 | Film No.: 26808883
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)